Marcopolis.net Video Interview with Ibrahim Diawara, President and CEO of Cipharm, also available here http://marcopolis.net/ibrahim-diawara-competitive-advantage-and-vision-for-cipharm-0309.htm
"There are procedures put in place by the WHO and by the DPM here. We have been working by these guidelines for years but the certification requires quite a bit of money. The regulations for a factory built in 1988 are obviously not the same as the regulations nowadays and will not be the same as those of 2020 so we need to work on this. It will require more investment and new investors. We are not going to finish the development for the injectable products and then sit back and relax. I hope to increase capital in the coming years and develop the company to be a medium sized company and then even further. That is my dream", says Ibrahim Diawara.
To read the full transcript of the MarcoPolis interview with Ibrahim Diawara, President and CEO of Cipharm, visit Marcopolis.net http://marcopolis.net/cipharm-overview-of-the-pharmaceutical-industry-in-cote-divoire-0209.htm
